Osaic Holdings’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-40
Closed -$207 7805
2025
Q4
$207 Sell
40
-440
-92% -$2.26K ﹤0.01% 7579
2025
Q3
$2.5K Hold
480
﹤0.01% 7068
2025
Q2
$1.84K Sell
480
-400
-45% -$1.03K ﹤0.01% 6964
2025
Q1
$5.06K Buy
880
+300
+52% +$1.77K ﹤0.01% 6172
2024
Q4
$2.9K Sell
580
-100
-15% -$513 ﹤0.01% 6462
2024
Q3
$3.67K Hold
680
﹤0.01% 6351
2024
Q2
$2.25K Sell
680
-6,420
-90% -$25.1K ﹤0.01% 6552
2024
Q1
$23.2K Sell
7,100
-146
-2% -$480 ﹤0.01% 5258
2023
Q4
$25.4K Sell
7,246
-39,067
-84% -$121K ﹤0.01% 5362
2023
Q3
$309K Buy
46,313
+39,166
+548% +$291K ﹤0.01% 3661
2023
Q2
$60K Hold
7,147
﹤0.01% 4814
2023
Q1
$71K Buy
7,147
+1
+0% +$7 ﹤0.01% 4717
2022
Q4
$50K Sell
7,146
-168
-2% -$960 ﹤0.01% 4933
2022
Q3
$39K Hold
7,314
﹤0.01% 5070
2022
Q2
$30K Buy
7,314
+6,500
+799% +$22.4K ﹤0.01% 5330
2022
Q1
$4K Buy
814
+3
+0.4% +$12 ﹤0.01% 6561
2021
Q4
$4K Buy
811
+28
+4% +$214 ﹤0.01% 6722
2021
Q3
$6K Hold
783
﹤0.01% 6428
2021
Q2
$10K Sell
783
-217
-22% -$2.61K ﹤0.01% 6041
2021
Q1
$12K Buy
1,000
+211
+27% +$2.43K ﹤0.01% 5760
2020
Q4
$5K Hold
789
﹤0.01% 5760
2020
Q3
$6K Buy
789
+289
+58% +$1.87K ﹤0.01% 5478
2020
Q2
$2K Buy
+500
New +$1.83K ﹤0.01% 5756

Other funds holding ALDX

Osaic Holdings's ALDX Position: Q1 2026 in Review

Osaic Holdings sold out of Aldeyra Therapeutics (ALDX) in Q1 2026, closing a stake of 40 shares — an estimated $207 sold.

Osaic Holdings first reported a position in ALDX in Q2 2020 and held it in 23 quarters. The position peaked at $309K in Q3 2023. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • Osaic Holdings reported no remaining Aldeyra Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Osaic Holdings sold 40 Aldeyra Therapeutics shares in Q1 2026, an estimated $207.
  • Osaic Holdings first reported a position in Aldeyra Therapeutics in Q2 2020 and held it in 23 quarters.
  • Osaic Holdings's Aldeyra Therapeutics position peaked at $309K in Q3 2023.
  • 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.